New brain cancer drug to be tested at OU

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

Data pix.

OKLAHOMA CITY -- Wiping out one of the most aggressive forms of brain cancer. That's the hope of scientists at the Oklahoma Medical Research Foundation (OMRF), who have developed a new cancer-fighting drug.

It's called OKN-007 - a James Bond reference to a lethal agent. It will be used in a clinical trial with 13 patients at the new Stephenson Cancer Center at OU Medical Center.

The cancer is called glioblastoma, the most common type of brain tumor. It killed Yankees legend Bobby Murcer and Senator Ted Kennedy.

Doctors say this drug has had good success with stroke patients and are encouraged with pre-clinical trials.

"What we found is these particular compounds can reduce tumors, and in many cases, regress tumors down to almost nothing," Dr. Rheal Towner, Ph.D. with OMRF said at a Wednesday press conference.

More than 14,000 people will die from brain cancer this year, according to the American Cancer Society.

Doctors are hoping this drug will have positive results on those clinical patients within the next 18 months.

Latest News

More News

National News

More National

Washington D.C.

More Washington DC Bureau

Your Local Election HQ

More Your Local Election HQ

Latest News

More News


KFOR Podcasts

More Podcasts

Follow @KFOR on Twitter